Literature DB >> 14531960

Lymphoproliferation in autoimmunity and Sjögren's syndrome.

Michalis Voulgarelis1, Haralampos M Moutsopoulos.   

Abstract

Sjögren's syndrome is a chronic inflammatory process involving primarily the exocrine glands. Its association with lymphoma is well documented. A low-grade marginal-zone lymphoma related to mucosa-associated lymphoid tissue is the most common lymphoid neoplasia in Sjögren's syndrome. Among all autoimmune diseases, Sjögren's syndrome is the best tool to clarify the multiple components of autoimmunity and lymphomatogenesis. Herewith, the authors review the literature and discuss the molecular, clinical, histopathologic, and therapeutic aspects of these tumors in Sjögren's syndrome.

Entities:  

Mesh:

Year:  2003        PMID: 14531960     DOI: 10.1007/s11926-003-0011-y

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  49 in total

Review 1.  Lymphomas in patients with Sjögren's syndrome: review of the literature and physiopathologic hypothesis.

Authors:  X Mariette
Journal:  Leuk Lymphoma       Date:  1999-03

2.  Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses.

Authors:  B Royer; D Cazals-Hatem; J Sibilia; F Agbalika; J M Cayuela; T Soussi; F Maloisel; J P Clauvel; J C Brouet; X Mariette
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

3.  The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome.

Authors:  L G Anderson; N Talal
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

4.  Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome.

Authors:  G Valesini; R Priori; D Bavoillot; J Osborn; M G Danieli; N Del Papa; R Gerli; M Pietrogrande; M G Sabbadini; F Silvestris; L Valsecchi
Journal:  J Rheumatol       Date:  1997-12       Impact factor: 4.666

5.  Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue.

Authors:  A Dogan; M Du; A Koulis; M J Briskin; P G Isaacson
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

6.  Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia.

Authors:  V De Re; S De Vita; A Marzotto; M Rupolo; A Gloghini; B Pivetta; D Gasparotto; A Carbone; M Boiocchi
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

7.  Lack of Fas and Fas-L mutations in patients with lymphoproliferative disorders associated with Sjögren's syndrome and type II mixed cryoglobulinemia.

Authors:  F Bertolo; S De Vita; R Dolcetti; A Carbone; G F Ferraccioli; E Bartoli; M Boiocchi
Journal:  Clin Exp Rheumatol       Date:  1999 May-Jun       Impact factor: 4.473

8.  Detection of clonally expanded salivary gland lymphocytes in Sjögren's syndrome.

Authors:  B Freimark; R Fantozzi; R Bone; G Bordin; R Fox
Journal:  Arthritis Rheum       Date:  1989-07

9.  Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells.

Authors:  T Martin; J C Weber; H Levallois; N Labouret; A Soley; S Koenig; A S Korganow; J L Pasquali
Journal:  Arthritis Rheum       Date:  2000-04

10.  Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues.

Authors:  R J Pelstring; J H Essell; P J Kurtin; A R Cohen; P M Banks
Journal:  Am J Clin Pathol       Date:  1991-12       Impact factor: 2.493

View more
  12 in total

Review 1.  Sjögren's syndrome: an old tale with a new twist.

Authors:  Byung Ha Lee; Mauro A Tudares; Cuong Q Nguyen
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-02-14       Impact factor: 4.291

Review 2.  Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease.

Authors:  Cuong Q Nguyen; Ammon B Peck
Journal:  Ocul Surf       Date:  2009-01       Impact factor: 5.033

Review 3.  Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca.

Authors:  Katy C Liu; Kyle Huynh; Joseph Grubbs; Richard M Davis
Journal:  Curr Allergy Asthma Rep       Date:  2014-01       Impact factor: 4.806

Review 4.  What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome?

Authors:  Ammon B Peck; Cuong Q Nguyen
Journal:  Clin Immunol       Date:  2017-05-03       Impact factor: 3.969

5.  Transcriptome analysis of the interferon-signature defining the autoimmune process of Sjögren's syndrome.

Authors:  A B Peck; C Q Nguyen
Journal:  Scand J Immunol       Date:  2012-09       Impact factor: 3.487

6.  Histopathological changes in tear-secreting tissues and cornea in a mouse model of autoimmune disease.

Authors:  Masaya Hiraishi; Md Abdul Masum; Takashi Namba; Yuki Otani; Yaser Ha Elewa; Osamu Ichii; Yasuhiro Kon
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-21

Review 7.  The important role of T cells and receptor expression in Sjögren's syndrome.

Authors:  A Karabiyik; A B Peck; C Q Nguyen
Journal:  Scand J Immunol       Date:  2013-08       Impact factor: 3.487

8.  IL-22 regulation of functional gene expression in salivary gland cells.

Authors:  Tegan N Lavoie; Wendy C Carcamo; Arun Wanchoo; Ashok Sharma; Afife Gulec; Kathleen M Berg; Carol M Stewart; Cuong Q Nguyen
Journal:  Genom Data       Date:  2015-11-22

9.  The Interferon-Signature of Sjögren's Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific Diseases.

Authors:  Cuong Quoc Nguyen; Ammon Broughton Peck
Journal:  Front Immunol       Date:  2013-07-05       Impact factor: 7.561

10.  Anti-salivary gland protein 1 antibodies in two patients with Sjogren's syndrome: two case reports.

Authors:  Sahana Vishwanath; Long Shen; Lakshmanan Suresh; Julian L Ambrus
Journal:  J Med Case Rep       Date:  2014-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.